Impairment testing changes the numbers and story presented by consolidated financial statements because it adjusts the carrying amounts of assets and goodwill to reflect recoverable value. Guidance from the IASB staff International Accounting Standards Board explains that recoverable amount is the higher of fair value less costs of disposal and value in use. PwC Accounting Research Team PricewaterhouseCoopers notes that impairment losses flow through consolidated profit or loss and reduce parent company equity and possibly non-controlling interests, creating immediate effects on ratios, debt covenants, and stakeholder perception.
Recognition and measurement mechanics
When a cash-generating unit contains goodwill, impairment testing requires allocation of goodwill to that unit and comparison of carrying amount to recoverable amount. If the carrying amount exceeds the recoverable amount, an impairment loss is recognised. This is often driven by economic causes such as market contraction, technological obsolescence, or adverse regulatory change. For consolidated groups, the loss is first applied to goodwill and then to other assets pro rata to their carrying amounts except where specific rules apply. The accounting treatment also creates deferred tax consequences because tax bases rarely move in lockstep with accounting carrying amounts.
Consolidation-specific consequences
Consolidated statements reflect impairment at the group level, which can mask or amplify local operational issues. In cross-border groups a currency devaluation or a change in local legal environment can trigger CGU impairment in one territory and alter consolidated profitability and equity materially. Cultural factors such as management reluctance to disclose bad news can delay recognition, increasing the size of prospective write-downs and undermining comparability. Impairments can lead to covenant breaches, renegotiation of financing, and reputational effects that affect access to capital in certain jurisdictions.
Beyond immediate profit or loss impact, impairment testing affects future periods through reduced depreciation charges, altered return on assets, and changes to performance-linked compensation. Because estimates underpinning value in use are sensitive to discount rates, growth assumptions, and cash flow projections, auditors and analysts look to transparent disclosures and robust methodology. The combined guidance from IASB staff International Accounting Standards Board and practical analysis from PwC Accounting Research Team PricewaterhouseCoopers underscores that rigorous impairment testing is central to reliable consolidated reporting and to the stewardship and decision-usefulness roles of financial statements.